Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, a case of post-COVID telogen effluvium was reported in which fever and stress following COVID-19 triggered temporary hair loss, and topical treatment showed positive results in improving this condition.

This article reviews current diagnostic and treatment approaches for androgenetic alopecia but reports no new results, focusing on its progression and medical management options.

This study examined 15 female patients with hypothyroidism to investigate the characterization of their alopecia and ruled out other causes, using medical histories, and clinical, trichoscopic, and histologic findings.

In this case report, the authors identified giant cell arteritis as the underlying cause of bitemporal hair loss and scalp tenderness in a 70-year-old woman, initially misdiagnosed as age-related symptoms.

This study observed that a majority of female patients with chronic telogen effluvium had low serum ferritin levels without signs of clinical anemia, suggesting a possible link between low iron stores and hair loss.

This study observed that bitemporal alopecia often coincides with conditions such as androgenetic alopecia, seborrheic dermatitis, and telogen effluvium. The researchers suggest bitemporal hair loss could help predict and monitor these associated hair diseases.

Early diagnosis and treatment can help manage fibrosing alopecia in older women.

This study demonstrates that an AI-based grading framework using a novel area ratio metric improves the accuracy and consistency of male pattern hair loss classification, especially in advanced grades, compared to traditional methods.

This review examines the various potential causes of bitemporal hair loss, emphasizing the importance of prompt diagnosis to prevent further hair loss in scarring conditions; it reports no new clinical results.

In this study of female patients with chronic telogen effluvium, 86% had low serum ferritin levels despite only 32% having anemia, suggesting a potential link between low iron stores and this type of hair loss.

This case report describes a 24-year-old woman with traction alopecia, highlighting that if the excessive traction is not addressed, it can progress from reversible to permanent hair loss.

This case report describes a patient with lichen nitidus whose lesions improved following treatment with oral astemizole and topical steroids, although spontaneous resolution remains a possibility.

This correspondence reports that some men with androgenetic alopecia can exhibit hair thinning patterns more typical of females, with variations observed between Australian and Korean populations.

This review discusses the genetic research developments in androgenetic alopecia, reporting no new clinical results, and highlights the potential for discovering novel therapeutic targets.

This study found that the prevalence of androgenetic alopecia increases with age among both men and women in Maryborough, Australia, with 57% of women and 73.5% of men aged 80 and over affected.

This study identified acute localized telogen effluvium as a histopathologic mechanism for temporal hair loss following rhytidectomy.

In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.

This study identified acute localized telogen effluvium as a potential cause of temporal hair loss following rhytidectomy.

This study examined the follicular unit density in the scalp and beard donor areas of Indian men undergoing hair restoration surgery, reporting mean densities of 78.2/cm² and 49.7/cm² respectively, and proposed guidelines for safe follicular unit extraction.

This review describes advances in alopecia-reducing procedures for cosmetic hair restoration, highlighting benefits and challenges, but reports no new clinical findings.

This paper presents an interactive quiz related to a study by Deng et al. (2022) in the Journal of Investigative Dermatology, examining androgen receptor-mediated paracrine signaling in androgenetic alopecia, but it provides no new clinical findings.

Recent studies highlighted in this research suggest that alopecia types in men, traditionally thought to affect only certain scalp areas, can also impact the occipital region, which was previously presumed unaffected.

This report describes a case of temporary hair loss due to telogen effluvium after rhytidectomy, suggesting dermatologic surgeons consider preventive measures to minimize trauma and tension on hair follicles during surgery.

In this case report, a 31-year-old man with frontal hairline recession saw a marked improvement in hair density and scalp appearance after undergoing six mesotherapy sessions alongside twice-daily application of 5% minoxidil, attributed to the treatment protocol combining nutrients, bioactives, and topical minoxidil.

This study reports that severe androgenic alopecia prevalence in young Caucasian men increases with age, varies by region, and that body mass index may be a risk factor.

This case report illustrates how SNP array testing helped identify a DCAF17 mutation linked to Woodhouse-Sakati syndrome in consanguineous Qatari siblings with shared features including alopecia and hypogonadotropic hypogonadism.

The researchers reported that various environmental factors and higher testosterone levels were linked to different patterns of hair loss in women with androgenic alopecia.

In this study, trichoscopic examination revealed that variations in hair diameter were more common in certain types of alopecia affecting the frontal scalp, suggesting the importance of evaluating the entire scalp for accurate diagnoses, although limitations include a single center design and small sample size.

In this randomized controlled trial, researchers found that Cellcurin therapy significantly increased hair density, terminal hair, and vellus hair counts in men and women with androgenetic alopecia, compared to minoxidil control, over 12 weeks.

This review discusses advances in molecular biology and genetics related to androgenetic alopecia and reports no new clinical results.